Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014736718> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2014736718 endingPage "385???391" @default.
- W2014736718 startingPage "385???391" @default.
- W2014736718 abstract "A common presentation for major depression includes psychomotor agitation. However, this subtype has been the infrequent subject of controlled investigation during depression trials. Yet, the subcategorization of agitated depression has historically been associated with the belief that older, sedating compounds have a superior risk:benefit profile. In the 8-week, double-blind, randomized, parallel trial, 124 subjects with Research Diagnostic Criteria-compatible agitated depression were randomized to either imipramine (IMI) or fluoxetine (FLU). Both compounds proved to be similarly effective as measured by change in HAM-D17, HAM-D17 response, and HAM-D17 remission rates. Similar comparability was seen in secondary measures of agitation, anxiety, suicidality, and global impressions. However, of note, a statistically significant difference in early discontinuations because of intolerable adverse events emerged. Whereas 43.5% of IMI subjects discontinued early, only 9.7% of FLU subjects (p < 0.001) did. Significantly more central nervous system events characterized the IMI than the FLU subgroup (IMI, 24.2%, vs. FLU, 6.5%; p = 0.006). In conclusion, among subjects with major depression, subtype agitated, the risk:benefit profile favored FLU over IMI. This was driven by the superior tolerance of FLU. No evidence emerged in support of the clinical hypothesis that a “sedating” agent is the treatment of choice for this group. The results are important when striving to maximize compliance with pharmacotherapy in order to minimize recidivism and associated psychological and economic morbidity. (J Clin Psychopharmacol 1994;14:385–391)" @default.
- W2014736718 created "2016-06-24" @default.
- W2014736718 creator A5011597490 @default.
- W2014736718 creator A5015947165 @default.
- W2014736718 creator A5024791837 @default.
- W2014736718 creator A5032744893 @default.
- W2014736718 creator A5057661359 @default.
- W2014736718 creator A5064151665 @default.
- W2014736718 creator A5083635360 @default.
- W2014736718 date "1994-12-01" @default.
- W2014736718 modified "2023-09-27" @default.
- W2014736718 title "Is Baseline Agitation a Relative Contraindication for a Selective Serotonin Reuptake Inhibitor" @default.
- W2014736718 doi "https://doi.org/10.1097/00004714-199412000-00003" @default.
- W2014736718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7884018" @default.
- W2014736718 hasPublicationYear "1994" @default.
- W2014736718 type Work @default.
- W2014736718 sameAs 2014736718 @default.
- W2014736718 citedByCount "34" @default.
- W2014736718 countsByYear W20147367182013 @default.
- W2014736718 crossrefType "journal-article" @default.
- W2014736718 hasAuthorship W2014736718A5011597490 @default.
- W2014736718 hasAuthorship W2014736718A5015947165 @default.
- W2014736718 hasAuthorship W2014736718A5024791837 @default.
- W2014736718 hasAuthorship W2014736718A5032744893 @default.
- W2014736718 hasAuthorship W2014736718A5057661359 @default.
- W2014736718 hasAuthorship W2014736718A5064151665 @default.
- W2014736718 hasAuthorship W2014736718A5083635360 @default.
- W2014736718 hasConcept C118552586 @default.
- W2014736718 hasConcept C126322002 @default.
- W2014736718 hasConcept C139719470 @default.
- W2014736718 hasConcept C142724271 @default.
- W2014736718 hasConcept C15744967 @default.
- W2014736718 hasConcept C162324750 @default.
- W2014736718 hasConcept C168563851 @default.
- W2014736718 hasConcept C170493617 @default.
- W2014736718 hasConcept C197934379 @default.
- W2014736718 hasConcept C204787440 @default.
- W2014736718 hasConcept C2775864247 @default.
- W2014736718 hasConcept C2776134451 @default.
- W2014736718 hasConcept C2776494729 @default.
- W2014736718 hasConcept C2776867660 @default.
- W2014736718 hasConcept C2778715236 @default.
- W2014736718 hasConcept C558461103 @default.
- W2014736718 hasConcept C71924100 @default.
- W2014736718 hasConceptScore W2014736718C118552586 @default.
- W2014736718 hasConceptScore W2014736718C126322002 @default.
- W2014736718 hasConceptScore W2014736718C139719470 @default.
- W2014736718 hasConceptScore W2014736718C142724271 @default.
- W2014736718 hasConceptScore W2014736718C15744967 @default.
- W2014736718 hasConceptScore W2014736718C162324750 @default.
- W2014736718 hasConceptScore W2014736718C168563851 @default.
- W2014736718 hasConceptScore W2014736718C170493617 @default.
- W2014736718 hasConceptScore W2014736718C197934379 @default.
- W2014736718 hasConceptScore W2014736718C204787440 @default.
- W2014736718 hasConceptScore W2014736718C2775864247 @default.
- W2014736718 hasConceptScore W2014736718C2776134451 @default.
- W2014736718 hasConceptScore W2014736718C2776494729 @default.
- W2014736718 hasConceptScore W2014736718C2776867660 @default.
- W2014736718 hasConceptScore W2014736718C2778715236 @default.
- W2014736718 hasConceptScore W2014736718C558461103 @default.
- W2014736718 hasConceptScore W2014736718C71924100 @default.
- W2014736718 hasIssue "6" @default.
- W2014736718 hasLocation W20147367181 @default.
- W2014736718 hasLocation W20147367182 @default.
- W2014736718 hasOpenAccess W2014736718 @default.
- W2014736718 hasPrimaryLocation W20147367181 @default.
- W2014736718 hasRelatedWork W1968895338 @default.
- W2014736718 hasRelatedWork W1993082943 @default.
- W2014736718 hasRelatedWork W2015255754 @default.
- W2014736718 hasRelatedWork W2034112753 @default.
- W2014736718 hasRelatedWork W2059313976 @default.
- W2014736718 hasRelatedWork W2324126613 @default.
- W2014736718 hasRelatedWork W2748952813 @default.
- W2014736718 hasRelatedWork W2782315116 @default.
- W2014736718 hasRelatedWork W2899084033 @default.
- W2014736718 hasRelatedWork W4376872105 @default.
- W2014736718 hasVolume "14" @default.
- W2014736718 isParatext "false" @default.
- W2014736718 isRetracted "false" @default.
- W2014736718 magId "2014736718" @default.
- W2014736718 workType "article" @default.